J&J Unit Slams Diabetes Drug Blood Disorder Claims
A Johnson & Johnson unit has hit back at allegations that its Type 2 diabetes drug Invokana caused a man to contract the potentially life-threatening condition diabetic ketoacidosis, telling a Pennsylvania...To view the full article, register now.
Already a subscriber? Click here to view full article